Skip to main content

and
  1. Article

    Open Access

    Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade

    New molecular targets are needed for women with triple-negative breast cancer (TNBC). This pre-clinical study investigated the combination of the EGFR inhibitor gefitinib with the sphingosine kinase (SphK) inh...

    Janet L. Martin, Sohel M. Julovi, Mike Z. Lin in Breast Cancer Research (2017)